Dose-dense chemotherapy in advanced ovarian cancer (Q84574339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Dose-dense chemotherapy in advanced ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

Michael A Bookman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

18 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

9698

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1303-1305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

Weekly paclitaxel in the adjuvant treatment of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer an

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

Is inhibition of cancer angiogenesis and growth by paclitaxel schedule dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line--a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2

7 January 2021

10.1016/S0140-6736(09)61305-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference